Description
Product details
Polycan B 5L IU Injection Generic Name: Polymyxin B for Injection USP Strength: 5 Lakh IU Dosage Form: Injection Therapeutic Class: Polymyxin Antibiotic Product Introduction Polycan B 5L IU Injection contains Polymyxin B, an antibacterial medicine generally reserved for the management of serious infections caused by susceptible Gram-negative bacteria, particularly when treatment options are limited. Antibacterial Action Polymyxin B interacts with the bacterial cell membrane, disrupting its integrity and causing leakage of essential cellular components, which leads to bacterial cell death. Clinical Relevance Polymyxin B may have activity against susceptible Gram-negative organisms such as: Pseudomonas aeruginosa Acinetobacter species Klebsiella species Certain other multidrug-resistant Gram-negative bacteria Actual treatment should be guided by culture and antimicrobial susceptibility results whenever possible. Key Monitoring Requirements During systemic Polymyxin B therapy, healthcare professionals may monitor: Kidney function Neurological symptoms Clinical response to treatment Signs of hypersensitivity Concurrent nephrotoxic medicines Important Safety Information Major risks associated with systemic Polymyxin B include nephrotoxicity and neurotoxicity. Neuromuscular blockade and respiratory complications can also occur in serious cases. Appropriate medical monitoring is therefore important during therapy.
